{"id":32064,"date":"2026-02-09T02:03:27","date_gmt":"2026-02-09T02:03:27","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/fibrotic-disease-treatment-market-mordor\/"},"modified":"2026-09-11T03:10:26","modified_gmt":"2026-09-10T18:10:26","slug":"fibrotic-disease-treatment-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/fibrotic-disease-treatment-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc12c\uc720\ud654 \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2025-2030\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/fibrotic-disease-treatment-market_1684852915862_123.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/fibrotic-disease-treatment-market-size-image-1735470812284.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \uc5ed\ud559<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \ud761\uc5f0 \uc778\uad6c \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc \uae30\uc220 \ubc1c\uc804<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc57d\ubb3c \ubc0f \uce58\ub8cc \ube44\uc6a9\uc758 \ub192\uc740 \uac00\uaca9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \ubaa8\ub2c8\ud130\ub9c1\uc744 \uc704\ud55c \ud6a8\uacfc\uc801\uc778 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc0f \uc9c4\ub2e8 \ub3c4\uad6c \ubd80\uc871<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uc138\ubd84\ud654<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc57d\ubb3c \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc7a5\uae30 \uc774\uc2dd<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc0b0\uc18c \uc694\ubc95<\/li>\n<li class=\"toc-level-3\">5.1.4 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d<\/li>\n<li class=\"toc-level-3\">5.2.2 \uac04\uacbd\ubcc0\uc99d<\/li>\n<li class=\"toc-level-3\">5.2.3 \uc2e0\uc7a5 \uc12c\uc720\uc99d<\/li>\n<li class=\"toc-level-3\">5.2.4 \ud53c\ubd80 \uc12c\uc720\uc99d<\/li>\n<li class=\"toc-level-3\">5.2.5 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.3.2 \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00<\/li>\n<li class=\"toc-level-3\">5.3.3 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.4.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.4.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.4.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.4.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.4.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.4.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.4.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.4.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.4.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.4.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.4.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.4.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.4.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.4.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.4.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.4.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.4.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \ud68c\uc0ac \ud504\ub85c\ud544\n<ul>\n<li class=\"toc-level-3\">6.1.1 Genentech, Inc<\/li>\n<li class=\"toc-level-3\">6.1.2 Boehringer Ingelheim International GmbH<\/li>\n<li class=\"toc-level-3\">6.1.3 AbbVie Inc.,<\/li>\n<li class=\"toc-level-3\">6.1.4 Redx Pharma Plc<\/li>\n<li class=\"toc-level-3\">6.1.5 Bristol-Myers Squibb Company<\/li>\n<li class=\"toc-level-3\">6.1.6 BioMX<\/li>\n<li class=\"toc-level-3\">6.1.7 Gilead Sciences, Inc.<\/li>\n<li class=\"toc-level-3\">6.1.8 KITHER BIOTECH S.R.L<\/li>\n<li class=\"toc-level-3\">6.1.9 Verona Pharma plc<\/li>\n<li class=\"toc-level-3\">6.1.10 Intercept Pharmaceuticals, Inc<\/li>\n<li class=\"toc-level-3\">6.1.11 Pharmaxis Ltd,<\/li>\n<li class=\"toc-level-3\">6.1.12 Sandoz International GmbH<\/li>\n<li class=\"toc-level-3\">6.1.13 Camber Pharmaceuticals<\/li>\n<\/ul>\n<\/li>\n<li><strong>*\ubaa9\ub85d\uc740 \uc644\uc804\ud558\uc9c0 \uc54a\uc74c<\/strong><\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \ub3d9\ud5a5<\/p>\n<div style=\"font-family:regular_semibold\">\uc774\uc6a9 \uac00\ub2a5 \uc5ec\ubd80\uc5d0 \ub530\ub984<\/div>\n<div style=\"font-family:regular_semibold\">\uacbd\uc7c1 \ud658\uacbd \ud3ec\ud568 &#8211; \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uc2e0 \ub3d9\ud5a5<\/div><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc131\uc7a5 \uc804\ub9dd<\/p>\n<p>\uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04\uc778 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.2%\ub97c \uae30\ub85d\ud558\uba70 \uacac\uace0\ud55c \uc131\uc7a5\uc744 \uc774\ub8f0 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774 \uc2dc\uc7a5\uc740 \uce58\ub8cc\ubc95(\uc57d\ubb3c \uce58\ub8cc, \uc7a5\uae30 \uc774\uc2dd, \uc0b0\uc18c \uc694\ubc95 \ub4f1), \uc801\uc6a9 \ubd84\uc57c(\ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d, \uac04\uacbd\ubcc0\uc99d, \uc2e0\uc7a5 \uc12c\uc720\uc99d, \ud53c\ubd80 \uc12c\uc720\uc99d \ub4f1), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\ubcd1\uc6d0, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00 \ub4f1), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4. \ud2b9\ud788 \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>COVID-19\uc758 \uc601\ud5a5<\/p>\n<p>COVID-19 \ud32c\ub370\ubbf9\uc740 \uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ucd08\uae30\uc5d0\ub294 \ubd80\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\ucce4\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 COVID-19 \ud3d0\ub834\uc758 \ud6c4\uc720\uc99d\uc73c\ub85c \ud3d0 \uc12c\uc720\uc99d \uc774\ud615\uc131\uc99d\uc774 \ubc1c\uc0dd\ud560 \uac00\ub2a5\uc131\uc774 \uc81c\uae30\ub418\uba74\uc11c, \ud32c\ub370\ubbf9 \uc774\ud6c4 \uc12c\uc720\uc99d \uce58\ub8cc\uc5d0 \ub300\ud55c \uc0c1\ub2f9\ud55c \uc218\uc694\ub97c \ucc3d\ucd9c\ud588\uc2b5\ub2c8\ub2e4. 2022\ub144 5\uc6d4 Annals of Medicine and Surgery\uc5d0 \ubc1c\ud45c\ub41c \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74, COVID-19 \uc0dd\uc874\uc790\uc758 \uc57d 44.9%\uac00 \ud3d0 \uc12c\uc720\uc99d\uc744 \uc553\uac8c \ub41c \uac83\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \uc774\ub294 COVID-19 \uac10\uc5fc\uc790\ub4e4\uc774 \uc12c\uc720\uc99d \uc9c8\ud658\uc5d0 \ub354 \ucde8\uc57d\ud558\uba70, \ud32c\ub370\ubbf9 \uae30\uac04 \ub3d9\uc548 \uc12c\uc720\uc99d \uce58\ub8cc\uc5d0 \ub300\ud55c \uc218\uc694\uac00 \uc2e4\uc9c8\uc801\uc73c\ub85c \uc99d\uac00\ud588\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ucd94\uc138\ub294 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc2dc\uc7a5\uc758 \uafb8\uc900\ud55c \uc131\uc7a5\uc744 \ub4b7\ubc1b\uce68\ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\ub825<\/p>\n<p>\uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc774\ub044\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c\ub294 \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc99d\uac00\ud558\ub294 \ubd80\ub2f4, \ud761\uc5f0 \uc778\uad6c\uc758 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc12c\uc720\uc99d \uce58\ub8cc \uae30\uc220\uc758 \ubc1c\uc804\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>1.  \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \ubd80\ub2f4 \uc99d\uac00: \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d(IPF), \uac04\uacbd\ubcc0\uc99d, \uc2e0\uc7a5 \uc12c\uc720\uc99d, \ud53c\ubd80 \uc12c\uc720\uc99d \ub4f1 \ub2e4\uc591\ud55c \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00\ub294 \ud6a8\uacfc\uc801\uc778 \uce58\ub8cc\uc81c \uc218\uc694\ub97c \ucd09\uc9c4\ud558\ub294 \ud575\uc2ec \uc694\uc778\uc785\ub2c8\ub2e4. \ubbf8\uad6d \ud3d0 \ud611\ud68c(American Lung Association)\uc758 2022\ub144 11\uc6d4 \uc5c5\ub370\uc774\ud2b8 \ub370\uc774\ud130\uc5d0 \ub530\ub974\uba74, \ubbf8\uad6d\uc5d0\uc11c \ub9e4\ub144 \uc57d 5\ub9cc \uac74\uc758 \uc0c8\ub85c\uc6b4 IPF \uc0ac\ub840\uac00 \uc9c4\ub2e8\ub418\uba70, \ub300\ubd80\ubd84\uc758 IPF \ud658\uc790\ub294 50\uc138\uc5d0\uc11c 70\uc138 \uc0ac\uc774\uc5d0 \uc99d\uc0c1\uc744 \ucc98\uc74c \uc778\uc9c0\ud569\ub2c8\ub2e4. \ub610\ud55c, 2022\ub144 9\uc6d4 British Medical Journal\uc5d0 \ubc1c\ud45c\ub41c \uae30\uc0ac\uc5d0\uc11c\ub294 2021\ub144 \ud2b9\uc218 \uce58\ub8cc\ub97c \ubc1b\ub294 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d\uc758 \uc720\ubcd1\ub960\uc774 10\ub9cc \uba85\ub2f9 36.0\uba85\uc73c\ub85c \ucd94\uc815\ub418\uc5c8\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc9c0\uc18d\uc801\uc778 \uc99d\uac00\ub294 \uc9c8\ubcd1\uc744 \ud6a8\uacfc\uc801\uc73c\ub85c \uad00\ub9ac\ud558\uace0 \ud1b5\uc81c\ud558\uae30 \uc704\ud55c \uce58\ub8cc\uc81c \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ucf1c \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ud06c\uac8c \uae30\uc5ec\ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>2.  \ud761\uc5f0 \uc778\uad6c \uc99d\uac00: \ud761\uc5f0\uc740 \ud3d0 \uc12c\uc720\uc99d\uacfc \uac19\uc740 \uc12c\uc720\uc99d \uc9c8\ud658 \ubc1c\ubcd1\uc758 \uc8fc\uc694 \uc704\ud5d8 \uc694\uc18c \uc911 \ud558\ub098\uc785\ub2c8\ub2e4. \ubbf8\uad6d \uc9c8\ubcd1\ud1b5\uc81c\uc608\ubc29\uc13c\ud130(CDC)\uc758 2023\ub144 5\uc6d4 \uc5c5\ub370\uc774\ud2b8\uc5d0 \ub530\ub974\uba74, 2021\ub144 \ubbf8\uad6d \uc131\uc778(18\uc138 \uc774\uc0c1) 100\uba85 \uc911 \uc57d 12\uba85(11.5%)\uc774 \ub2f4\ubc30\ub97c \ud53c\uc6e0\uc73c\uba70, \uc774\ub294 2,830\ub9cc \uba85\uc758 \uc131\uc778 \ud761\uc5f0\uc790\ub97c \uc758\ubbf8\ud569\ub2c8\ub2e4. \ub2f4\ubc30\uc5d0 \ud3ec\ud568\ub41c \ubbf8\ub9bd\uc790 \ubb3c\uc9c8\uacfc \uc218\ub9ce\uc740 \ud654\ud559 \ubb3c\uc9c8\uc740 \uccb4\ub0b4 \uc5fc\uc99d\uc744 \uc99d\uac00\uc2dc\ucf1c \uc12c\uc720\uc99d \uc9c8\ud658\uc744 \ud3ec\ud568\ud55c \ub2e4\uc591\ud55c \uc9c8\ubcd1\uc73c\ub85c \uc774\uc5b4\uc9c8 \uc218 \uc788\uc73c\uba70, \uc774\ub294 \uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud558\ub294 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>3.  \uae30\uc220 \ubc1c\uc804 \ubc0f \uc804\ub7b5\uc801 \ud65c\ub3d9: \uc2e0\uc81c\ud488 \ucd9c\uc2dc, \ud30c\ud2b8\ub108\uc2ed, \uc778\uc218\ud569\ubcd1 \ub4f1 \uae30\uc5c5\ub4e4\uc758 \uc804\ub7b5\uc801 \ud65c\ub3d9\uc740 \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624 \ud655\uc7a5\uacfc \uc9c0\ub9ac\uc801 \uc785\uc9c0 \uac15\ud654\ub97c \ud1b5\ud574 \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, 2022\ub144 5\uc6d4 Sandoz\ub294 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d(IPF) \uce58\ub8cc\ub97c \uc704\ud55c \uc81c\ub124\ub9ad \ud53c\ub974\ud398\ub2c8\ub3c8(pirfenidone)\uc744 \ucd9c\uc2dc\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub294 Genentech\uc758 Esbriet\uc640 \ub3d9\ub4f1\ud55c \ucd5c\ucd08\uc758 AB \ub4f1\uae09(\uc644\uc804\ud788 \ub300\uccb4 \uac00\ub2a5\ud55c) \uc81c\ub124\ub9ad \uc758\uc57d\ud488\uc73c\ub85c, \uc801\uaca9 \ud658\uc790\uc5d0\uac8c\ub294 0\ub2ec\ub7ec\uc758 \ubcf8\uc778 \ubd80\ub2f4\uae08 \ud504\ub85c\uadf8\ub7a8\uc774 \uc81c\uacf5\ub418\uc5b4 \uce58\ub8cc \uc811\uadfc\uc131\uc744 \ub192\uc774\uace0 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud560 \uac83\uc73c\ub85c \uae30\ub300\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc694\uc778\ub4e4\uc774 \ubcf5\ud569\uc801\uc73c\ub85c \uc791\uc6a9\ud558\uc5ec \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc2dc\uc7a5\uc5d0 \uae0d\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce60 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>\uadf8\ub7ec\ub098 \uc12c\uc720\uc99d \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30<\/p>\n<p>1.  \uc57d\ubb3c \uce58\ub8cc \ubd80\ubb38\uc758 \uc9c0\ubc30\uc801 \uc810\uc720\uc728: \uc57d\ubb3c \uce58\ub8cc \ubd80\ubb38\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \ud601\uc2e0\uc801\uc778 \uc2e0\uc57d \uac1c\ubc1c\uc744 \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c \ud65c\ub3d9 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc758 \uc804\ub7b5\uc801 \ud65c\ub3d9\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub429\ub2c8\ub2e4. \ud53c\ub974\ud398\ub2c8\ub3c8(pirfenidone)\uacfc \ub2cc\ud14c\ub2e4\ub2d9(nintedanib)\uacfc \uac19\uc740 \uc57d\ubb3c\uc740 \uc9c8\ubcd1 \uc9c4\ud589\uc744 \ub2a6\ucd94\uace0 \ud3d0 \ud749\ud130 \ud615\uc131\uc5d0 \uae30\uc5ec\ud558\ub294 \uc0dd\ub9ac\uc801 \uacfc\uc815\uc744 \uc5b5\uc81c\ud558\uc5ec \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d(IPF)\uc758 \uc9c4\ud589\uc744 \uc608\ubc29\ud558\uace0 \ud658\uc790\uc758 \ud638\ud761\uc744 \ub3d5\uc2b5\ub2c8\ub2e4. \uc0b0\uc18c \uc694\ubc95 \ub610\ud55c \ud638\ud761 \uace4\ub780 \ud658\uc790\uc758 \ud65c\ub3d9\uc744 \ub3d5\ub294 \ub370 \uc0ac\uc6a9\ub429\ub2c8\ub2e4.<\/p>\n<p>    \uc5f0\uad6c \uac1c\ubc1c \ud65c\ub3d9\uc740 \ub2e4\uc591\ud55c \uc9c8\ubcd1 \uce58\ub8cc\ub97c \uc704\ud55c \uc0c8\ub85c\uc6b4 \uae38\uc744 \uc5f4\uc5b4\uc8fc\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uae30\uc220 \ubc1c\uc804\uacfc \uc801\uc808\ud55c \uc5f0\uad6c\ub294 \uc5ec\ub7ec \uc9c8\ubcd1 \uce58\ub8cc\ub97c \uc704\ud55c \uc57d\ubb3c \uac1c\ubc1c\ub85c \uc774\uc5b4\uc9d1\ub2c8\ub2e4. 2023\ub144 4\uc6d4 ClinicalTrial.gov\uc5d0 \ub530\ub974\uba74, 207\uac1c\uad6d\uc5d0\uc11c \uc12c\uc720\uc99d \uc9c8\ud658\uc5d0 \ub300\ud55c 5,001\uac74\uc758 \uc784\uc0c1 \uc2dc\ud5d8\uc774 \uc9c4\ud589 \uc911\uc785\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc0c8\ub85c\uc6b4 \uce58\ub8cc\ubc95 \uac1c\ubc1c \ub178\ub825\uc740 \uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \uc81c\uacf5\ud560 \uac83\uc785\ub2c8\ub2e4. \ub610\ud55c, \uc2e0\uc57d \ucd9c\uc2dc \uc99d\uac00\ub3c4 \uc774 \ubd80\ubb38\uc758 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. 2022\ub144 5\uc6d4 Sandoz\uc758 \uc81c\ub124\ub9ad \ud53c\ub974\ud398\ub2c8\ub3c8 \ucd9c\uc2dc \uc678\uc5d0\ub3c4, 2021\ub144 6\uc6d4 Genentech\ub294 Esbriet(pirfenidone)\uc5d0 \ub300\ud55c \ubbf8\uad6d \uc2dd\ud488\uc758\uc57d\uad6d(FDA)\uc758 \ubcf4\ucda9 \uc2e0\uc57d \uc2e0\uccad(sNDA)\uc5d0 \ub300\ud574 \uc6b0\uc120 \uc2ec\uc0ac\ub97c \ubc1b\uc558\uc2b5\ub2c8\ub2e4. 2022\ub144 6\uc6d4\uc5d0\ub294 Accord Healthcare, Inc.\ub3c4 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d \uce58\ub8cc\ub97c \uc704\ud574 Genentech\uc758 Esbriet\uc640 \uce58\ub8cc\uc801\uc73c\ub85c \ub3d9\ub4f1\ud55c \ud53c\ub974\ud398\ub2c8\ub3c8\uc744 \uc790\uc0ac \uc81c\ud488 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\uc5d0 \ucd94\uac00\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>2.  \ubd81\ubbf8 \uc2dc\uc7a5\uc758 \uc911\uc694\uc131: \ubd81\ubbf8 \uc9c0\uc5ed\uc740 \uc5f0\uad6c \uae30\uac04 \ub3d9\uc548 \uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \uacbd\ud5d8\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \ud3d0 \uc12c\uc720\uc99d \ubd80\ub2f4 \uc99d\uac00\uc640 \uce58\ub8cc \uae30\uc220 \ubc1c\uc804, \uadf8\ub9ac\uace0 \uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc758 \uc81c\ud488 \ucd9c\uc2dc \ubc0f \uc804\ub7b5\uc801 \uc774\ub2c8\uc154\ud2f0\ube0c\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4.<\/p>\n<p>    \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d(CF)\uacfc \uac19\uc740 \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \ubd80\ub2f4 \uc99d\uac00\ub294 \ubd81\ubbf8 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. 2021\ub144 \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uce90\ub098\ub2e4\uc758 41\uac1c \uacf5\uc778 CF \ud074\ub9ac\ub2c9\uc744 \ubc29\ubb38\ud55c \ub0ad\ud3ec\uc131 \uc12c\uc720\uc99d \ud658\uc790\ub294 \ucd1d 4,338\uba85\uc774\uc5c8\uc73c\uba70, \uc774 \uc911 98\uba85\uc774 \uc0c8\ub85c \uc9c4\ub2e8\ubc1b\uc558\uc2b5\ub2c8\ub2e4. \uce90\ub098\ub2e4 \uc804\uccb4 CF \uc778\uad6c\ub294 \uafb8\uc900\ud788 \uc99d\uac00\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uc12c\uc720\uc99d \uce58\ub8cc\uc81c \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ud0a4\ub294 \uc694\uc778\uc785\ub2c8\ub2e4.<\/p>\n<p>    \ubd81\ubbf8 \uc9c0\uc5ed\uc5d0\uc11c\ub294 \uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc\ub97c \uc704\ud55c \uc5f0\uad6c \uac1c\ubc1c \ud65c\ub3d9\uc774 \ud65c\ubc1c\ud558\uac8c \uc9c4\ud589\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. 2022\ub144 9\uc6d4 Bellerophon Therapeutics, Inc.\ub294 \uc12c\uc720\uc131 \uac04\uc9c8\uc131 \ud3d0 \uc9c8\ud658(ILD) \uce58\ub8cc\ub97c \uc704\ud55c INOpulse\uc758 REBUILD 3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8 \uaddc\ubaa8 \ucd95\uc18c \uc2e0\uccad\uc774 FDA\uc5d0 \uc758\ud574 \uc2b9\uc778\ub418\uc5c8\ub2e4\uace0 \ubc1d\ud614\uc2b5\ub2c8\ub2e4. 2022\ub144 10\uc6d4 Boehringer Ingelheim\uc740 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d(IPF) \ud658\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \ud558\ub294 BI 1015550(\uc2e4\ud5d8\uc801 \ud3ec\uc2a4\ud3ec\ub514\uc5d0\uc2a4\ud14c\ub77c\uc81c 4B(PDE4B) \uc5b5\uc81c\uc81c)\uc758 \uae00\ub85c\ubc8c 3\uc0c1 \uc784\uc0c1 \uc2dc\ud5d8\uc778 FIBRONEER-IPF\uc5d0 \ubbf8\uad6d \uccab \ud658\uc790\uac00 \ub4f1\ub85d\ub418\uc5c8\ub2e4\uace0 \ubcf4\uace0\ud588\uc2b5\ub2c8\ub2e4. \ub610\ud55c, FDA\uc758 \uc2e0\uc18d \uc2ec\uc0ac(Fast Track) \uc9c0\uc815\uc740 \uae30\uc5c5\ub4e4\uc774 \uae30\uc220\uc801\uc73c\ub85c \uc815\uad50\ud55c \uc81c\ud488\uc744 \uc2dc\uc7a5\uc5d0 \ucd9c\uc2dc\ud558\ub3c4\ub85d \uc7a5\ub824\ud558\uba70, \uc774\ub294 \ud604\ub300 \uce58\ub8cc\ubc95\uc758 \uac00\uc6a9\uc131\uc744 \ub192\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc608\ub97c \ub4e4\uc5b4, Istesso\uc758 BS2320 \uc57d\ubb3c \ud6c4\ubcf4\ub294 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d(IPF) \uce58\ub8cc\ub97c \uc704\ud574 FDA\ub85c\ubd80\ud130 \uc2e0\uc18d \uc2ec\uc0ac \uc9c0\uc815\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \uacbd\uc7c1 \uac15\ub3c4\ub97c \ubcf4\uc774\uba70, \uc18c\uc218\uc758 \uc8fc\uc694 \uae30\uc5c5\uacfc \ub2e4\uc218\uc758 \uc18c\uaddc\ubaa8 \uae30\uc5c5\uc73c\ub85c \uad6c\uc131\ub418\uc5b4 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc740 \ud611\ub825, \ud30c\ud2b8\ub108\uc2ed, \uc778\uc218\ud569\ubcd1, \uae00\ub85c\ubc8c \ud655\uc7a5 \ub4f1 \ub2e4\uc591\ud55c \uc804\ub7b5\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc5d0\uc11c \uac15\ub825\ud55c \uc785\uc9c0\ub97c \uad6c\ucd95\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\uc73c\ub85c\ub294 Boehringer Ingelheim International GmbH, AbbVie Inc., Redx Pharma Plc, Bristol-Myers Squibb Company, Gilead Sciences, Inc. \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>*   2023\ub144 5\uc6d4: Boehringer Ingelheim\uc740 \uc790\uc0ac\uc758 \ub3d9\uae09 \ucd5c\ucd08 IL-11 \uc5b5\uc81c\uc81c \ud56d\uccb4\uc778 BI 765423\uc758 \uc784\uc0c1 \uac1c\ubc1c\uc744 \uc2dc\uc791\ud588\uc73c\uba70, \uac74\uac15\ud55c \uc790\uc6d0\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \uc548\uc804\uc131, \ub0b4\uc57d\uc131 \ubc0f \uc57d\ub3d9\ud559\uc744 \ud3c9\uac00\ud558\ub294 1\uc0c1 \uc5f0\uad6c(NCT05658107)\ub97c \uc9c4\ud589 \uc911\uc785\ub2c8\ub2e4. \uc804\uc784\uc0c1 \uc5f0\uad6c\uc5d0\uc11c\ub294 \ud56d-IL-11 \uc57d\ubb3c\uc774 \uc5ec\ub7ec \uc12c\uc720\uc99d \uc9c8\ud658\uc5d0\uc11c \uc12c\uc720\uc99d\uc744 \uc5b5\uc81c\ud558\uace0 \uc2ec\uc9c0\uc5b4 \uc5ed\uc804\uc2dc\ud0ac \uac00\ub2a5\uc131\uc744 \ubcf4\uc5ec\uc8fc\uc5c8\uc2b5\ub2c8\ub2e4.<br \/>\n*   2023\ub144 5\uc6d4: Cumberland Pharmaceuticals Inc.\ub294 \uc9c4\ud589\uc131 \uc12c\uc720\uc131 \uac04\uc9c8\uc131 \ud3d0 \uc9c8\ud658\uc758 \uac00\uc7a5 \ud754\ud55c \ud615\ud0dc\uc778 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d \ud658\uc790\ub97c \ub300\uc0c1\uc73c\ub85c \ud558\ub294 2\uc0c1 \uc5f0\uad6c\ub97c \uc704\ud55c \uc784\uc0c1\uc2dc\ud5d8\uc6a9 \uc2e0\uc57d(IND) \uc2e0\uccad\uc774 FDA\uc758 \uc2b9\uc778\uc744 \ubc1b\uc558\ub2e4\uace0 \ubc1c\ud45c\ud588\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uacb0\ub860\uc801\uc73c\ub85c, \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc99d\uac00\ud558\ub294 \ubd80\ub2f4, \ud761\uc5f0 \uc778\uad6c, \uadf8\ub9ac\uace0 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc758 \uc804\ub7b5\uc801 \ud65c\ub3d9\uc774 \ubcf5\ud569\uc801\uc73c\ub85c \uc791\uc6a9\ud558\uc5ec \uc12c\uc720\uc99d \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uacac\uace0\ud55c \uc131\uc7a5\uc744 \uc9c0\uc18d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc804 \uc138\uacc4 \uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc12c\uc720\uc99d\uc740 \uc190\uc0c1\uc774\ub098 \uc0c1\ud574\uc5d0 \ub300\ud55c \ud68c\ubcf5 \ubc18\uc751\uc73c\ub85c \uc12c\uc720\uc131 \uacb0\ud569 \uc870\uc9c1\uc774 \ubc1c\ub2ec\ud558\ub294 \ud604\uc0c1\uc744 \uc758\ubbf8\ud558\uba70, \uc774\ub294 \uc815\uc0c1\uc801\uc778 \uce58\uc720 \uacfc\uc815\uc758 \uc77c\ubd80\uc77c \uc218\ub3c4 \uc788\uace0 \ubcd1\ub9ac\ud559\uc801 \uacfc\uc815\uc73c\ub85c \uacfc\ub3c4\ud55c \uc870\uc9c1 \uce68\ucc29\uc774 \ubc1c\uc0dd\ud558\ub294 \uacbd\uc6b0\ub97c \uc9c0\uce6d\ud558\uae30\ub3c4 \ud569\ub2c8\ub2e4. \ud1b5\uc81c\ub418\uc9c0 \uc54a\uace0 \uc9c4\ud589\uc131 \uc12c\uc720\uc99d\uc744 \ud2b9\uc9d5\uc73c\ub85c \ud558\ub294 \uc8fc\uc694 \uc9c8\ud658\uc73c\ub85c\ub294 \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d(IPF), \ube44\uc54c\ucf54\uc62c\uc131 \uc9c0\ubc29\uac04\uc5fc(NASH), \uc804\uc2e0 \uacbd\ud654\uc99d(SSc) \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ub3d9\ud5a5 (Market Dynamics)<br \/>\n\uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc720\ubcd1\ub960 \uc99d\uac00, \ud761\uc5f0 \uc778\uad6c\uc758 \uc99d\uac00, \uadf8\ub9ac\uace0 \uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc \uae30\uc220\uc758 \uc9c0\uc18d\uc801\uc778 \ubc1c\uc804\uc774 \uaf3d\ud799\ub2c8\ub2e4. \ubc18\uba74, \ub192\uc740 \uc57d\ubb3c \ubc0f \uce58\ub8cc \ube44\uc6a9, \uc12c\uc720\uc99d \uc9c8\ud658\uc758 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \ubaa8\ub2c8\ud130\ub9c1\uc744 \uc704\ud55c \ud6a8\uacfc\uc801\uc778 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc0f \uc9c4\ub2e8 \ub3c4\uad6c\uc758 \ubd80\uc871\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc8fc\uc694 \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611, \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825, \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825, \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611, \uacbd\uc7c1 \uac15\ub3c4 \ub4f1\uc744 \ud3ec\ud568\ud558\ub294 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uacbd\uc7c1 \ud658\uacbd\uc744 \uc2ec\uce35\uc801\uc73c\ub85c \ud3c9\uac00\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc138\ubd84\ud654 (Market Segmentation)<br \/>\n\uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5\uc740 \ub2e4\uc74c\uacfc \uac19\uc774 \uc138\ubd84\ud654\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc\ubc95\ubcc4: \uc57d\ubb3c \uce58\ub8cc, \uc7a5\uae30 \uc774\uc2dd, \uc0b0\uc18c \uc694\ubc95, \uae30\ud0c0.<br \/>\n*   \uc801\uc6a9 \ubd84\uc57c\ubcc4: \ud2b9\ubc1c\uc131 \ud3d0\uc12c\uc720\uc99d, \uac04\uacbd\ubcc0\uc99d, \uc2e0\uc7a5 \uc12c\uc720\uc99d, \ud53c\ubd80 \uc12c\uc720\uc99d, \uae30\ud0c0.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \ubcd1\uc6d0, \ud559\uc220 \ubc0f \uc5f0\uad6c \uae30\uad00, \uae30\ud0c0 (\uc815\ubd80 \uae30\uad00 \ud3ec\ud568).<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8(\ubbf8\uad6d, \uce90\ub098\ub2e4, \uba55\uc2dc\ucf54), \uc720\ub7fd(\ub3c5\uc77c, \uc601\uad6d, \ud504\ub791\uc2a4, \uc774\ud0c8\ub9ac\uc544, \uc2a4\ud398\uc778, \uae30\ud0c0 \uc720\ub7fd), \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591(\uc911\uad6d, \uc77c\ubcf8, \uc778\ub3c4, \ud638\uc8fc, \ud55c\uad6d, \uae30\ud0c0 \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591), \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74(GCC, \ub0a8\uc544\ud504\ub9ac\uce74, \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74), \ub0a8\ubbf8(\ube0c\ub77c\uc9c8, \uc544\ub974\ud5e8\ud2f0\ub098, \uae30\ud0c0 \ub0a8\ubbf8). \ubcf8 \ubcf4\uace0\uc11c\ub294 \uc804 \uc138\uacc4 \uc8fc\uc694 \uc9c0\uc5ed\uc5d0 \uac78\uccd0 17\uac1c\uad6d\uc758 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 \ub3d9\ud5a5\uc744 \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc804\ub9dd (Market Size &#038; Forecast)<br \/>\n\uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uc5f0\ud3c9\uade0 7.2%\uc758 \uc131\uc7a5\ub960(CAGR)\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \ubcf4\uace0\uc11c\ub294 2019\ub144\ubd80\ud130 2024\ub144\uae4c\uc9c0\uc758 \uacfc\uac70 \uc2dc\uc7a5 \uaddc\ubaa8\uc640 2025\ub144\ubd80\ud130 2030\ub144\uae4c\uc9c0\uc758 \uc608\uce21 \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc9c0\uc5ed \ub3d9\ud5a5 (Key Regional Trends)<br \/>\n2025\ub144 \uae30\uc900, \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5\uc5d0\uc11c \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud55c\ud3b8, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04(2025-2030\ub144) \ub3d9\uc548 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd (Competitive Landscape)<br \/>\n\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub85c\ub294 Boehringer Ingelheim International GmbH, AbbVie Inc., Redx Pharma Plc, Bristol-Myers Squibb Company, Gilead Sciences, Inc. \ub4f1\uc774 \uc788\uc73c\uba70, \uc774 \uc678\uc5d0\ub3c4 Genentech, Inc., BioMX, KITHER BIOTECH S.R.L, Verona Pharma plc, Intercept Pharmaceuticals, Inc, Pharmaxis Ltd, Sandoz International GmbH, Camber Pharmaceuticals \ub4f1 \ub2e4\uc218\uc758 \uae30\uc5c5\uc774 \uacbd\uc7c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc740 \uac01 \uae30\uc5c5\uc758 \uc0ac\uc5c5 \uac1c\uc694, \uc7ac\ubb34, \uc81c\ud488 \ubc0f \uc804\ub7b5, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ub4f1\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc12c\uc720\uc99d \uc9c8\ud658 \uce58\ub8cc \uc2dc\uc7a5\uc758 \ud604\uc7ac \ubc0f \ubbf8\ub798 \ub3d9\ud5a5, \uc8fc\uc694 \uc131\uc7a5 \ub3d9\uc778\uacfc \uc81c\uc57d \uc694\uc778, \uc138\ubd84\ud654\ub41c \uc2dc\uc7a5 \ubd84\uc11d, \uc9c0\uc5ed\ubcc4 \uc804\ub9dd, \uadf8\ub9ac\uace0 \uc8fc\uc694 \uacbd\uc7c1\uc0ac \uc815\ubcf4\ub97c \uc81c\uacf5\ud558\uc5ec \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc774 \uc804\ub7b5\uc801 \uc758\uc0ac\uacb0\uc815\uc744 \ub0b4\ub9ac\ub294 \ub370 \ud544\uc694\ud55c \uc2ec\uce35\uc801\uc778 \ud1b5\ucc30\ub825\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-32064","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/32064"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=32064"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/32064\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=32064"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=32064"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=32064"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}